Ipsen S.A. engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Welcome to the official Facebook page for Ipsen. Learn more at: www.ipsen.com
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care.
It develops and commercializes innovative medici...
See More
nes in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business.
With total sales close to €1.6 billion in 2016, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US).
The Group has about 5,100 employees worldwide.